Neogen Chemicals Announces Leadership Transition and Q1 FY2026 Results
Neogen Chemicals Limited reported significant leadership changes and financial results for Q1 FY2026. Founder Haridas Kanani will retire as Chairman and Managing Director on September 30, 2025, becoming Chairman Emeritus. Anurag Surana will assume the role of Chairman from October 1, 2025. The company reported Q1 FY2026 revenue of ₹184.58 crores and net profit of ₹14.23 crores. Additional corporate actions include scheduling the 36th AGM, approving a ₹125 crore corporate guarantee for its subsidiary, and planning to raise ₹200 crores through non-convertible debentures. Neogen also expanded its global presence through subsidiary developments in Japan.

*this image is generated using AI for illustrative purposes only.
Neogen Chemicals Limited , a leading specialty chemicals manufacturer, has announced significant changes in its leadership structure along with its financial results for the first quarter of fiscal year 2026.
Leadership Transition
The company's Board of Directors has approved a series of leadership changes, marking a new chapter in Neogen's corporate governance:
Chairman and Managing Director Retirement: Mr. Haridas Kanani, the founder and current Chairman and Managing Director, will retire on September 30, 2025. In recognition of his visionary leadership and outstanding contributions, the Board has conferred upon him the honorary title of 'Chairman Emeritus' effective October 1, 2025.
New Chairman Appointment: Mr. Anurag Surana, currently serving as a Non-Executive Non-Independent Director, will assume the role of Chairman and Non-Executive Non-Independent Director from October 1, 2025.
Executive Director Appointment: The Board has recommended the appointment of Mr. Triplicane Commandoor Narasimhan Saikrishnan as Executive Director for a five-year term, starting October 1, 2025.
Whole Time Director Re-appointment: Mr. Shyamsunder Upadhyay has been re-appointed as Whole Time Director for a three-year term, commencing October 1, 2025.
Financial Performance
Neogen Chemicals reported its standalone financial results for Q1 FY2026 (quarter ended June 30, 2025):
Particulars | Q1 FY2026 (₹ in crores) |
---|---|
Revenue | 184.58 |
Net Profit | 14.23 |
The company's performance demonstrates resilience in a challenging economic environment.
Corporate Actions
In addition to the leadership changes, Neogen Chemicals has taken several corporate actions:
The 36th Annual General Meeting is scheduled for September 26, 2025.
The Board has approved an additional corporate guarantee of ₹125 crores for its wholly-owned subsidiary, Neogen Ionics Limited.
The company is planning to raise funds up to ₹200 crores through the issuance of non-convertible debentures on a private placement basis.
Subsidiary Developments
Neogen Chemicals continues to expand its global footprint:
Neogen Ionics Limited, a wholly-owned subsidiary, has incorporated a new entity named Neogen Morita New Materials Limited on July 30, 2025.
The company has invested JPY 200,00,000 (equivalent to ₹1.19 crores) in Neogen Chemicals Japan Corporation Limited, its wholly-owned subsidiary in Japan.
These strategic moves are expected to strengthen Neogen's position in the specialty chemicals market and drive future growth.
As Neogen Chemicals navigates through this transition period, the company remains committed to its core values of excellence, integrity, and innovation in the specialty chemicals sector.
Historical Stock Returns for Neogen Chemicals
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.91% | -5.58% | -9.39% | -32.85% | -7.61% | +131.25% |